Skip to main content

Published locations for HER2+ BC: Adding pyrotinib to neoadjuvant trastuzumab+docetaxel shows promise in phase 3 study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2+ BC: Adding pyrotinib to neoadjuvant trastuzumab+docetaxel shows promise in phase 3 study

User login

  • Reset your password
  • /content/her2-bc-adding-pyrotinib-neoadjuvant-trastuzumabdocetaxel-shows-promise-phase-3-study
  • /hematology-oncology/article/260834/breast-cancer/her2-bc-adding-pyrotinib-neoadjuvant